Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
Glutaminase inhibition (GLSi) has promising activity against certain cancers. Here, the authors show that GLSi has no effect on multiple mouse models of pancreatic cancer and characterize the metabolic pathways activated in response to GLSi whose concomitant inhibition may have therapeutic utility.
Saved in:
Main Authors: | Douglas E. Biancur, Joao A. Paulo, Beata Małachowska, Maria Quiles Del Rey, Cristovão M. Sousa, Xiaoxu Wang, Albert S. W. Sohn, Gerald C. Chu, Steven P. Gygi, J. Wade Harper, Wojciech Fendler, Joseph D. Mancias, Alec C. Kimmelman |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/3c1c97f9f96f44b8b385caffd639b374 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting glutamine metabolism slows soft tissue sarcoma growth
by: Pearl Lee, et al.
Published: (2020) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
by: Leal Oburoglu, et al.
Published: (2021) -
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer
by: Manabu Kodama, et al.
Published: (2020) -
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
by: Ru Chen, et al.
Published: (2017) -
Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia
by: Yuanyuan Wang, et al.
Published: (2019)